Ruslan G. Guseinov

Ruslan G. Guseinov

Auto-generated profile, based on publicly available information

Ruslan G. Guseinov

St. Luka’s Clinical Hospital; Saint Petersburg State University

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2023 in Cancer Urology
Verified
Journal Article
Open access
PDF file
SPS. V. Popov
S. V. Popov
RGR. G. Guseynov
R. G. Guseynov
VKV. V. Khizha
V. V. Khizha
AYA. V. Yazenok
A. V. Yazenok
IOI. N. Orlov
I. N. Orlov
AUA. S. Ulitina
A. S. Ulitina
Background. Prostate cancer is one of the most common malignant neoplasms in the male population worldwide with high morbidity and mortality rates.Aim. To study the main medial statistical indicators of prostate cancer in Saint Petersburg and other regions of the Russian Federation.Materials and methods. The epidemiological indicators of prostate cancer for 2012-2021 in the Russian Federation, individual federal districts and Saint Petersburg were analyzed.Results. The prevalence of malignant neoplasms of the prostate has increased in recent years. At the same time, the number of cases of early-stage disease diagnosis has increased, one-year mortality has decreased, and 5-year survival has increased, which indicates proper quality of oncological care for the population. In some federal districts, unstable or negative dynamics of indicators compared to the average Russian data are observed, which requires further analysis.Conclusion. Evaluation of statistical measures of morbidity and mortality from malignant neoplasms of the prostate gland can be used to improve diagnostic algorithms and therapeutic tactics for this pathology.

13 July 2018 in Urologiia
Verified
Journal Article
Closed access
SPS.V. Popov Popov
S.V. Popov Popov
RGR.G. Guseinov Guseinov
R.G. Guseinov Guseinov
OSO.N. Skryabin Skryabin
O.N. Skryabin Skryabin
IOI.N. Orlov Orlov
I.N. Orlov Orlov
AMA.G. Martov Martov
A.G. Martov Martov
FFFmba Of Russia A.I. Burnazyan Ssc Fmbc
Fmba Of Russia A.I. Burnazyan Ssc Fmbc
Currently, prostate biopsy remains the main method used to diagnose prostate cancer (PCa). The indication for the procedure is an elevated level of the serum level of the total prostate-specific antigen (PSA). However, the PSA test is organ- but not cancer-specific, and patients may undergo an unnecessary biopsy, which is an invasive procedure associated with a risk of complications. Additional tests have been developed aimed to improve the diagnostic performance of PSA for detecting PCa. They include PSA derivatives such as free PSA fraction, -2proPSA, PSA density, PHI and the free /total PSA fraction. To investigate the diagnostic accuracy of PSA and its derivatives in detecting benign and malignant diseases of the prostate after an initial prostate biopsy. The current study analyzed 65 initial biopsies performed due to an elevated serum PSA level and compared them with the results of extended PSA testing with the use of PSA derivatives. The histological findings consistent with PCa were found in about 30% of initial biopsies performed due to elevated serum levels of total PSA. The incidence of histologically confirmed PCa increased with age, and 70-79 year old men were more likely to have it than 60-69 years old patients. PSA density in 85% of PCa cases exceeded that for benign prostatic hyperplasia (BPH). In all PCa patients, PHI and free /total PSA fraction were greater than 25 and less than 0.15, respectively. In most patients with BPH, the PHI and free /total PSA fraction did not exceed 25 and were greater than 0.15. 1. Initial biopsy triggered by elevated serum level of total PSA allows detection of PCa in about 30% of cases. 2. The age of 60 years and older should be regarded as a risk factor for PCa. The probability of malignant transformation of prostate epithelial cells in men over 70 years of age is greater than in 60-69-year-olds. 3. The density of PSA in men with morphologically verified PCa is statistically significantly greater than that in men with BPH and the threshold value in 85% of cases. 4. Determination of PHI and free/total PSA fraction can improve the accuracy of predicting malignant lesions of the prostate and adjust the indications for histological examination, reduce the number of unnecessary biopsies. 5. When defining indications for initial prostate biopsy in cases with serum PSA varying from 2 to 10 ng/ml, PSA derivatives should be used, including PSA density, prostate health index, and the free /total PSA fraction.

20 September 2017 in Urologiia
Verified
Journal Article
Closed access
SPS.V. Popov Popov
S.V. Popov Popov
RGR.G. Guseinov Guseinov
R.G. Guseinov Guseinov
AMA.G. Martov Martov
A.G. Martov Martov
TMT.M. Muratov Muratov
T.M. Muratov Muratov
NTN.B. Tabynbaev Tabynbaev
N.B. Tabynbaev Tabynbaev
A№Astana Regional Hospital №2
Astana Regional Hospital №2

14 August 2023 in Cancer Urology
Verified
Journal Article
Open access
PDF file
SPS. V. Popov
S. V. Popov
RGR. G. Guseynov
R. G. Guseynov
VKV. V. Khizha
V. V. Khizha
AYA. V. Yazenok
A. V. Yazenok
KSKonstantin Sivak
Konstantin Sivak
TLTatiana Александровна Lelyavina
Tatiana Александровна Lelyavina
Background. Bladder cancer is the most common malignancy of the urinary tract and one of the most common neoplasias in this group. The incidence and mortality rates of the population from bladder cancer differ significantly in different geographical regions of Russia.Aim. To assess the main epidemiological indicators of malignant neoplasms of the bladder in residents of Saint Petersburg and the regions of Russia.Materials and methods. The main epidemiological indicators of malignant bladder neoplasms in Saint Petersburg, Russia and individual federal districts for the period 2012–2021 were studied: crude and standardized rates of morbidity, mortality, prevalence, age structure of patients, the number of cases of diagnosis of the disease at various stages, indicators of one-year mortality and 5-year survival, data on completed cases of treatment of bladder neoplasms. Sources of information: Form No. 7 “Information on cases of malignant diseases” and the database of the Medical Information and Analytical Center (Saint Petersburg).Results. During the period 2012–2021 in Russia, there was an increase in the incidence and prevalence of malignant neoplasms of the bladder. At the same time, mortality rates decreased, and 5-year survival rates increased. This fact indicates the effectiveness of the treatment of patients in this category. In more than 50 % of cases, the disease was detected at stage I of the pathological process, which is due to the proper level of diagnosis. The main medical and statistical indicators in patients with malignant bladder neoplasms in Saint Petersburg are comparable to the average Russian data, and in a number of parameters they exceed them.Conclusion. Oncourological assistance to the population with malignant neoplasms of the bladder in Saint Petersburg is provided properly. The study of medical and statistical indicators in dynamics can be used to improve the algorithms of medical and diagnostic care for cancer patients.

8 April 2019 in Research and Practical Medicine Journal
Verified
Journal Article
Open access
PDF file
SPS. V. Popov
S. V. Popov
RGR. G. Guseynov
R. G. Guseynov
OSO. N. Skryabin
O. N. Skryabin
IOI. N. Orlov
I. N. Orlov
AVA. A. Vorobyov
A. A. Vorobyov
VSV. L. Shchukin
V. L. Shchukin
ИММУНОГИСТОХИМИЧЕСКИЙ АНАЛИЗ КАК МЕТОД ПОВЫШЕНИЯ ВЫЯВЛЯЕМОСТИ РАКА ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ ПРИ ПЕРВИЧНОЙ БИОПСИИ

3 December 2022 in Cancer Urology
Verified
Journal Article
Open access
PDF file
SPS V Popov
S V Popov
RGR G Guseynov
R G Guseynov
IOI N Orlov
I N Orlov
KSKonstantin Sivak
Konstantin Sivak
OSO N Skryabin
O N Skryabin
AZA S Zaytsev
A S Zaytsev
Background. Radical prostatectomy in treatment of locally advanced prostate cancer is currently recommended as one of the stages of multimodal therapy. Despite this, the expediency of surgical intervention remains a subject of discussion: based on the results of their own research, supporters of surgical tactics for treatment of locally advanced prostate cancer point to the effectiveness and relative safety of radical prostatectomy, opponents point to the high probability of a positive surgical edge associated with the operation, local tumor recurrence, lymphogenic metastasis, and formation of distant metastases.Aim. To evaluate the outcomes of laparoscopic radical prostatectomy performed in combination with expanded pelvic lymphadenectomy in treatment of prostate adenocarcinoma T3a–3bN0M0.Materials and methods. The perioperative, functional, and oncological results of surgical treatment of patients with locally advanced prostate cancer (n = 32) aged between 46 years to 71 years were analyzed. The follow-up period averaged 9–36 months (median 13 months).Results. Mean total duration of surgical intervention and mean volume of intraoperative blood loss were 182.69 ± 3.99 minutes and 253.06 ± 9.80 ml, respectively. Overestimation of the clinical stage of the disease, according to histological examination of the surgical material, was observed in 6.3 % of patients. After the intervention, the function of urinary retention was preserved and did not require correction in 65.6 % of men. In all patients 6 months after the operation, the urinary volume, maximum and mean urine flow rates were normalized, and there was a trend toward a decrease in the post-void residual volume. During the entire follow-up period, there were no signs of biochemical relapse in 78.1 % of patients. None of the participants dropped out of the study due to death.Conclusion. Over the last 20 years in specialized medical periodicals, author teams from various countries have shown the immediate and remote (follow-up period from 3 to 20 years) outcomes of radical surgical treatment of locally advanced prostate cancer in at least 80,000 patients in total, while the criterion for exclusion from research was adjuvant therapy. The authors’ conclusions indicate the effectiveness and relative safety of surgical treatment of locally advanced prostate cancer, as well as the importance of extended pelvic lymphadenectomy, which allows to optimize the tactics of adjuvant therapy if necessary. The results of our own observations are completely comparable with the literature data. Currently, scientific research is continuing with the aim of improving the outcomes of surgical treatment of locally advanced prostate cancer, in particular clarifying the role of individual prognostic factors, improving prediction techniques and choosing a rational scheme of treatment measures.